A study using a PET scan tracer has identified, for the first time, epigenetic differences between the brains of individuals with schizophrenia and those of unaffected study participants. In their report published online in the Journal of Clinical Investigation, the team describes measuring differences in the expression of histone deacetylase (HDAC) enzymes, important regulators of gene transcription, in a brain structure known to be important for key cognitive functions. While reduced HDAC levels had previously been observed in postmortem brain samples from patients with schizophrenia, use of the tracer, named Martinostat, allows measurement of HDACs in the brains of living individuals.
"HDAC enzymes can profoundly influence gene expression in the brain and may alter cognition," says lead author. "With Martinostat, instead of being confined to analyzing small tissue samples, as in earlier studies, we can now assay HDAC expression and distribution across the entire living brain in a single PET scan. Beyond comparisons between healthy and disease states, this will enable long-term studies exploring the relationship between HDAC levels and disease onset, progression and symptom severity."
This is the first to use the tracer to compare HDAC levels in the brains of living individuals with and without a neuropsychiatric disorder. Previous animal studies had linked disruption of HDAC levels to cognitive issues, such as memory formation, and HDAC inhibitors have had beneficial effects in mouse models of several neuropsychiatric and neurodegenerative diseases.
For the current study the investigators focused on HDAC levels in the dorsolateral prefrontal cortex (DLPFC), a brain region known to be important for aspects of executive functions - such as working memory, planning and flexibility - that are impaired in people with schizophrenia. A previous study from the research team had observed lower expression of an important HDAC in DLFPC tissue from deceased patients with schizophrenia than in tissue from unaffected individuals.
The current study enrolled 14 individuals with schizophrenia or the related schizoaffective disorder, all receiving long-term treatment for moderately severe symptoms, and 17 healthy control volunteers. All participants completed a standard assessment of cognitive functions typically affected by schizophrenia, and those with schizophrenia had an interview to assess symptom severity prior to PET scanning with the Martinostat tracer.
As expected, the scans revealed that Martinostat uptake indicating binding to HDAC2 - the enzyme that was reduced in the postmortem study - was significantly lower in the DLFPC of participants with schizophrenia than in the control group, with levels of reduction corresponding with worse cognitive performance scores. An analysis of Martinostat uptake across the whole brain indicated not only that HDAC expression was lower in some structures adjacent to the DLFPC but, unexpectedly, that it was higher in cerebral white matter and in the cerebellum, structures that also have been associated with schizophrenia.
"While we found preliminary correlations between the relative Martinostat signal in the cerebral white matter and multiple aspects of cognitive testing - such as processing speed and working memory - we don't yet know which types of cognitive factors HDAC is most closely correlated with," says the lead author. "Moving forward we hope to apply advanced cognitive measures to our studies to help better understand the relationship between HDAC levels and human cognition."
https://www.jci.org/articles/view/123743
https://www.massgeneral.org/about/pressrelease.aspx?id=2324
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fpet-neuroimaging&filter=22
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
New pathway for accumulation of age-promoting 'zombie cells'
Read more
How EGF receptor sends signals into cells
Read more
Endogenous receptor surface mobility during synaptic plasticity and…
Read more
Recording gene expression order in DNA by CRISPR addition of retron…
Read more
Mechanisms and inhibition of Porcupine-mediated Wnt acylation
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar